Change Country
Welcome to UKWelcome
Please read the important information below before continuing to our website

Please read the important information below before continuing to our website.  

By clicking on your client type to enter the website, you are confirming that you have read and understood the important information that is contained below, and you accept the terms of the Privacy and Cookies policy.


The information on this website is published in the UK by Lyxor Asset Management UK LLP (Lyxor UK), which is authorized by Financial Conduct Authority in the UK, under FCA Registration Number 435658.


The website is hosted by on Microsoft Azure servers.

This website is subject to French law and English Law


A professional client is a client that is either a per se professional client or an elective professional client  (Note article 4 (1) 12 of Mifid )


A professional client is one of the following:

– an entity required to be authorised or regulated to operate in the financial markets. The following list includes all authorised entities carrying out the characteristic activities of the entities mentioned, whether authorised by an EEA State or a third country and whether or not authorised by reference to a directive:

  • a credit institution
  • an investment firm
  • any other authorised or regulated financial institution
  • an insurance company
  • a collective investment scheme or the management company of such a scheme
  • a pension fund or the management company of a pension fund
  • a commodity or commodity derivatives dealer
  • a local
  • any other institutional investor

– in relation to MiFID or equivalent third country business, a large undertaking, meeting two of the following size requirements on a company basis:

  • balance sheet total of EUR 20,000,000
  • net turnover of EUR 40,000,000
  • own funds of EUR 2,000,000

– in relation to business that is neither MiFID or equivalent third country business, a large undertaking meeting either of the following conditions:

  • a body corporate (including a limited liability partnership) which has (or any of whose holding companies or subsidiaries has) called up share capital of at least £10 million (or its equivalent in any other currency at the relevant time)
  • a large undertaking that meets (or any of whose holding companies or subsidiaries meets) two of the following tests: (i) a balance sheet total of EUR 12,500,000; (ii) a net turnover of EUR 25,000,000; (iii) an average number of employees during the year of 250
  • a national or regional government, a public body that manages public debt, a central bank, an international or supranational institution (such as the World Bank, the IMF, the ECP, the EIB) or another similar international organisation.
  • another institutional investor whose main activity is to invest in financial instruments (in relation to the firm's MiFID or equivalent third country business) or designated investments (in relation to the firm's other business). This includes entities dedicated to the securitisation of assets or other financing transactions.


The above definition is only an extract and is not exhaustive. For further details please refer to the Glossary section of the FCA Handbook:



Lyxor and Lyxor ETF are names used by Lyxor Asset Management UK LLP to promote the products of Lyxor International Asset Management. Although information contained herein is from sources believed to be reliable, Lyxor UK makes no representation or warranty regarding the accuracy af any information. Any reproduction, disclosure or dissemination of these materials is prohibited. This site is maintained by Lyxor UK, SG House, 41 Towar Hill, London EC3N 4SG.



Marketing Restrictions and Implications


Lyxor UCITS compliant Exchange Traded Funds (Lyxor UCITS ETFs) referred to on this website are open ended mutual investment funds (i) established under the French law and approved by the Autorité des Marchés Financiers (the French Financial Markets Authority), or (ii) established under the Luxembourg law and approved by the Commission de Surveillance du Secteur Financier (the Luxembourg Financial Supervisory Committee). Most, if not all, of the protections provided by the UK regulatory system generally and for UK authorised funds do not apply to these exchange traded funds (ETFs). In particular, investors should note that holdings in this product will not be covered by the provisions of the Financial Services Compensation Scheme, or by any similar scheme in France.


This website is exclusively intended for persons who are not "US persons", as such term is defined in Regulation S or the US Securities Act 1933, as amended, and who are not physically present in the US. This website does not constitute an offer or an invitation to purchase any securities in the United States or in any other jurisdiction in which such offer or invitation is not authorised or to any person to whom it is unlawful to make such offer or solicitation. Potential users of this website are requested to inform themselves about and to observe any such restrictions.





Index Replication Process


Lyxor UCITS ETFs follow both physical and synthetic index replication process.


However, most Lyxor UCITS ETFs follow synthetic replication process. This consists of entering into a derivative transaction (a ‘Performance Swap’, as defined below) with a counterparty that provides complete and effective exposure to its benchmark index. Lyxor has adopted this methodology in order to minimise tracking error, optimise transaction costs and reduce operational risks.


A Performance Swap is a contractual agreement which is negotiated over-the-counter (OTC) between two parties: the Lyxor UCITS ETF and its counterparty. From a risk perspective, each Performance Swap ranks equally with other senior unsecured obligations of the counterparty, such as common bonds (i.e., same rights to payments). In the Performance Swap, the counterparty of the Lyxor UCITS ETF commits to pay the Lyxor UCITS ETF a variable return based on a pre-determined benchmark index, instead of a fixed stream of income (as in bonds). At the same time, the counterparty will receive from the Lyxor UCITS ETF the performance and any related revenues generated by the basket's assets (excluding the value of the Performance Swap) held by the Lyxor UCITS ETF. Information provided on individual ETFs includes data on the basket relating to the ETF and the percentage value of the basket represented by each asset. The information is relevant to the closing values on the date given. 


Investment Risks


The Lyxor UCITS ETFs described on this website are not suitable for everyone. Investors' capital is at risk. Investors should not deal in this product unless they understand, having obtained independent professional advice where necessary, its nature, terms and conditions, and the extent of their exposure to risk. The value of the product can go down as well as up and can be subject to volatility due to factors such as price changes in the underlying instrument and interest rates. If a fund is quoted in a different currency to the index, currency risks exist.


Prior to any investment in any Lyxor UCITS ETF, you should make your own appraisal of the risks from a financial, legal and tax perspective, without relying exclusively on the information provided by us. We recommend that you consult your own independent professional advisors (including legal, tax, financial or accounting advisors, as appropriate).


Specific Risks


·         Capital at Risk. ETFs are tracking instruments: Their risk profile is similar to a direct investment in the Benchmark Index. Investors’ capital is fully at risk and investors may not get back the amount originally invested. Investments are not covered by the provisions of the Financial Services Compensation Scheme (“FSCS”), or any similar scheme.

·         Counterparty Risk. Investors may be exposed to risks resulting from the use of an OTC Swap with Societe Generale. Physical ETFs may have Counterparty Risk resulting from the use of a Securities Lending Programme.

·         Currency Risk. ETFs may be exposed to currency risk if the ETF or Benchmark Index holdings are denominated in a currency different to that of the Benchmark Index they are tracking. This means that exchange rate fluctuations could have a negative or positive effect on returns.

·         Replication Risk. ETFs are designed to replicate the performance of the Benchmark Index. Unexpected events relating to the constituents of the Benchmark Index may impact the Index provider’s ability to calculate the Benchmark Index, which may affect the ETF’s ability to replicate the Benchmark Index efficiently. This may create Tracking Error in the ETF.

·         Underlying Risk. The Benchmark Index of a Lyxor ETF may be complex and volatile. When investing in commodities, the Benchmark Index is calculated with reference to commodity futures contracts which can expose investors to risks related to the cost of carry and transportation. ETFs exposed to Emerging Markets carry a greater risk of potential loss than investment in Developed Markets as they are exposed to a wide range of unpredictable Emerging Market risks.

·         Liquidity Risk. On-exchange liquidity may be limited as a result of a suspension in the underlying market represented by the Benchmark Index tracked by the ETF; a failure in the systems of one of the relevant stock exchanges, Societe Generale or other Market Maker systems; or an abnormal trading situation or event.


The securities can be neither offered in nor transferred to the United States.




Any statement in relation to tax, where made, is generic and non-exhaustive and is based on our understanding of the laws and practice in force as of the date of this document and is subject to any changes in law and practice and the interpretation and application thereof, which changes could be made with retroactive effect. Any such statement must not be construed as tax advice and must not be relied upon. The tax treatment of investments will, inter alia, depend on an individual’s circumstances. Investors must consult with an appropriate professional tax adviser to ascertain for themselves the taxation consequences of acquiring, holding and/or disposing of any investments mentioned on this website. 


Further information on the risk factors are available in the [Risk Warning – link to risk page] section of the website.


Any fund prospectus and supplements are available at Information given about the past performance of the funds is no guarantee of future performance. No investment decision should be taken without reading the Legal Documents relating to the particuler Exchange Traded Fund concerned. A copy of the Legal Documents may be obtained from Lyxor UK at SG House, 41 Tower Hill, London EC3N 4SG upon request. 


Although the content of the website is based upon information that Lyxor UK consider reliable or comes from sources that Lyxor UK consider reliable, Lyxor UK has not verified such information. Lyxor UK make no representation or warranty as to the accuracy, completeness or adequacy of any information.  Any reproduction, disclosure or dissemination of the materials available on the website is prohibited.



This website uses cookies to make the website work or improve your user experience. Cookies are small text files that are saved on your computer or device, which are used for several purposes such as detecting preferences and improving site navigation. By continuing to use this website you consent for cookies to be used. For more details, including how to amend your preferences, please read our [Cookies Policy] link to privacy & cookie page.

By clicking on your client type to enter the website, you shall be deemed to have represented to us that you are not a U.S. person and that you are not located in the United States of America, its territories and possessions, and any State of the United States of America and that you are authorised to receive the information to and on this website.




17 Apr 2018

A bumpy road ahead for US assets (& what to do about it)

One of our key calls in our Q2 outlook was that the road ahead may not be as smooth as it was for US assets. For all that, economic growth still looks firm - consumption remains the strongest driver, backed by continued consumer optimism and substantial wage gains. The current expansionary phase will soon become the joint second-longest in the country’s history. Should it endure to next spring, it would be the longest ever. However, it is now showing signs of wear and tear.

Inflation is on the rise, so real consumption is outstripping income. The household savings rate has halved over the last couple of years, while rising delinquency rates for auto loans suggest early signs of consumer stress. Slower job growth and lower rates of savings means the recent tax cuts could be crucial – without them Trump’s bid to keep growth on trend may be doomed to failure. The question is whether they have gone far enough.

Fiscal push or fiscal nudge?

Last December’s tax reforms included a new corporate tax rate of 21%, the repeal of the corporate alternative minimum tax and full expensing of equipment for the next five years. The recent budget deal added further stimulus through federal spending. The amount likely to be injected into the US economy should exceed 1% of GDP each year. Yet, at this late stage of the cycle, the measures may not be entirely reflected in real activity. Overall, the fiscal push should add around 0.5% to growth this year – meaning a rate of around 2.75% by year end.

Whatever its real effects, it’s still an unprecedentedly large stimulus package at such a late stage of the cycle and it will, in our view, undoubtedly spur on inflation in all its forms. A tight labour market should push wage inflation past the 3% mark within months.  This would eventually pass through inflation prints and benefit US breakevens.

Equities are often viewed as being capable of hedging inflation – which has proven true, especially over longer timeframes and periods of moderate inflation. The view doesn’t always stand up to scrutiny over shorter periods of time however, especially when inflation is at extreme levels - our analysis shows equities don’t in fact outperform in these conditions.

Should investors dig deeper, they may find equity sectors like gold miners, oil, materials and financials, along with factors like value and yield are more correlated to inflation expectations and CPI and therefore more capable of riding the rise. Be more wary of their utilities, telecoms and consumer staples counterparts.

5-yr correlations: equity sectors and inflation expectations 

   SP 500              MSCI Equity sectors

Source: Bloomberg, Macrobond, Lyxor Cross Asset Research, 11 April 2018. Methodology:  we consider the 5Y correlation of monthly changes in equity sector indices (total return in %) and 10Y inflation breakevens on the other hand (monthly value change). For commodities we use total return indices and correlation is versus EMU inflation breakevens.

The fear of four  

The exceptional conditions that have artificially suppressed yields since the Global Financial Crisis should continue to fade. We’ve long expected at least three hikes from the Fed in 2018, and now believe the possibility of four 25 basis point hikes is greater. Tighter policy normalisation cannot be ruled out. We suspect ten-year Treasury yields will push some way past 3%, so we are underweight over the long term. Shorter-term however, they retain their safe haven appeal should risk aversion spike.

How far from here? 

The firmer wage growth at this late stage of the expansion is likely to dent corporate profitability. Margins could compress by about 0.5% per year, although the positive effects of tax reform will help to mitigate this to some degree. All told we expect solid earnings-per-share growth of around 9% this year but rather more sedate results next year as the cycle totters into its dotage. There may therefore only be limited upside for the mainstream indices like the S&P 500 Index from here – only products offering the lowest cost access, or the very best performance, merit consideration.

Trading insults, rather than ideas

Greater consumer spending may encourage more imports as the US is hitting its capacity constraints. Any widening of the trade deficit could add further political pressure to Trump’s tightwire trade agenda. The heady rhetoric and recent bout of brinkmanship seem more of negotiating tactic than they are a declaration of trade war or a U-turn on globalisation, not least because of looming mid-term elections. In our view, Trump won’t risk blowing up a bull market – one of few feelgood factors at his disposal - at such a time.

Q2 positioning 

So we still expect US equities to outperform bonds in Q2, albeit by a lesser margin than before.  That said, the President’s taste for battle may rattle some of the country’s more risk-averse trading partners. Expect outward-looking international firms to suffer more than their domestic-focused counterparts. As a result, we’re neutral on the outlook for the broader indices and our preference for selected themes, like favouring growth over value, and sectors.

Take capex for example; tax reform should help accelerate spending on non-residential investments and in technology, a sector representing 30% of current capex and around 35% of the S&P 500 Growth Index. Despite all the talk of a new tech bubble, valuations look merely stretched in places rather than speculative or bubbly.

Our one value-based call remains banks because of the sector’s cyclicality. Commercial and industrial loans look likely to rebound, which will boost profitability. Higher inflation expectations also tend to translate into better prospects. The Fed’s continued willingness to simplify regulation is the last of a powerful trio of clearly positive catalysts.

S&P 500 margins look                                               S&P500 Growth versus Value

vulnerable as the cycle matures

    S&P 500 margins look vulnerable         S&P500 Growth versus Value

Source: Lyxor International AM/ Investment Strategy, Macrobond as at 16 March 2018

In fixed income, away from our views on breakevens and treasuries, we’ve yet to really touch on credit. In our view, the picture is fairly bleak – especially for high yield because valuations appear high and the sector appears to be pricing in a growth rate far in excess of what’s likely to eventuate in 2018. Leverage levels and inherent illiquidity are also a concern.  

Why choose Lyxor for US assets?

Whatever you’re seeking to do in your US-related portfolio, we believe we can help. We offer 15+ routes to the market including Europe’s lowest-cost Core US equity ETF at just 0.04%, as well as the best-performing S&P 500 ETF your money can buy. So if the upside is limited, you get to make the most of the opportunity. You can also generate income with the cheapest quality income ETF on the European market or take out some insurance against the possibility of renewed volatility with our minimum variance product – which has reduced risk by nearly 18% since its inception. It’s also the most diverse of its kind. 

Learn more about the Core

We’re not just equity experts though. We also offer the cheapest US Treasuries, US corporate bond and US HY bond ETFs on the market - among them some of the best-performing and most efficient you’ll find.  You’ll also be able to adjust to the changing inflation picture with our US TIPS ETF and our unique US inflation expectations product.*

Key products 

UCITS table  

All data & opinion: Lyxor Cross Asset Research & Equity ETF teams, as at 11 April 2018 unless otherwise stated. Past performance is no guarantee of future returns. * All product data as at 31 January 2018 unless otherwise stated. All efficiency data is based on the efficiency indicator created by Lyxor’s ETF Research department in 2013. It examines 3 components of performance: tracking error, liquidity and spread purchase/sale. Each peer group includes the relevant Lyxor ETF share-class and the 4 largest ETF share-classes issued by other providers, representing market-share of at least 5% on the relative index. ETF sizes are considered as an average of AUM levels observed over the relevant time period. Detailed methodology may be found in the paper ‘Measuring Performance of Exchange Traded Funds’ by Marlène Hassine and Thierry Roncalli. Statements refer to European ETF market.

Risk Warning


Fund and charge data: Lyxor ETF, correct as at  11 April  2018.

This document is for the exclusive use of investors acting on their own account and categorized either as “Eligible Counterparties” or “Professional Clients” within the meaning of Markets in Financial Instruments Directive 2004/39/EC. These products comply with the UCITS Directive (2009/65/EC). Société Générale and Lyxor International Asset Management (LIAM) recommend that investors read carefully the “investment risks” section of the product’s documentation (prospectus and KIID). The prospectus and KIID are available free of charge on, and upon request to

The products mentioned are the object of market-making contracts, the purpose of which is to ensure the liquidity of the products on the London Stock Exchange, assuming normal market conditions and normally functioning computer systems. Units of a specific UCITS ETF managed by an asset manager and purchased on the secondary market cannot usually be sold directly back to the asset manager itself. Investors must buy and sell units on a secondary market with the assistance of an intermediary (e.g. a stockbroker) and may incur fees for doing so. In addition, investors may pay more than the current net asset value when buying units and may receive less than the current net asset value when selling them. Updated composition of the product’s investment portfolio is available on In addition, the indicative net asset value is published on the Reuters and Bloomberg pages of the product, and might also be mentioned on the websites of the stock exchanges where the product is listed.

Prior to investing in the product, investors should seek independent financial, tax, accounting and legal advice. It is each investor’s responsibility to ascertain that it is authorised to subscribe, or invest into this product. This document is of a commercial nature and not of a regulatory nature. This material is of a commercial nature and not a regulatory nature. This document does not constitute an offer, or an invitation to make an offer, from Société Générale, Lyxor Asset Management (together with its affiliates, Lyxor AM) or any of their respective subsidiaries to purchase or sell the product referred to herein.

Lyxor International Asset Management (LIAM), société par actions simplifiée having its registered office at Tours Société Générale, 17 cours Valmy, 92800 Puteaux (France), 418 862 215 RCS Nanterre, is authorized and regulated by the Autorité des Marchés Financiers (AMF) under the UCITS Directive (2009/65/EU) and the AIFM Directive (2011/31/EU). LIAM is represented in the UK by Lyxor Asset Management UK LLP, which is authorized and regulated by the Financial Conduct Authority in the UK under Registration Number 435658. Société Générale is a French credit institution (bank) authorised by the Autorité de contrôle prudentiel et de résolution (the French Prudential Control Authority).

Research disclaimer

Lyxor International Asset Management (“LIAM”) or its employees may have or maintain business relationships with companies covered in its research reports. As a result, investors should be aware that LIAM and its employees may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. Please see appendix at the end of this report for the analyst(s) certification(s), important disclosures and disclaimers. Alternatively, visit our global research disclosure website

Conflicts of interest 

This research contains the views, opinions and recommendations of Lyxor International Asset Management (“LIAM”) Cross Asset and ETF research analysts and/or strategists. To the extent that this research contains trade ideas based on macro views of economic market conditions or relative value, it may differ from the fundamental Cross Asset and ETF Research opinions and recommendations contained in Cross Asset and ETF Research sector or company research reports and from the views and opinions of other departments of LIAM and its affiliates. Lyxor Cross Asset and ETF research analysts and/or strategists routinely consult with LIAM sales and portfolio management personnel regarding market information including, but not limited to, pricing, spread levels and trading activity of ETFs tracking equity, fixed income and commodity indices. Trading desks may trade, or have traded, as principal on the basis of the research analyst(s) views and reports. Lyxor has mandatory research policies and procedures that are reasonably designed to (i) ensure that purported facts in research reports are based on reliable information and (ii) to prevent improper selective or tiered dissemination of research reports. In addition, research analysts receive compensation based, in part, on the quality and accuracy of their analysis, client feedback, competitive factors and LIAM’s total revenues including revenues from management fees and investment advisory fees and distribution fees.

Connect with us on linkedin